SZodixStudyAcademic Library
DashboardShelvesOpen accessMy libraryInboxNotesWriteLearnAlerts
More
Ask your libraryNotificationsQuick citeReview
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa
2 references·16 citing·39 second hop
Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa (2009)Impact of individual‐donation nucleic aci…A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)A new strategy for estimating…Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Detection of HIV-1 and HCV In…The prevalence of transfusion-transmitted infections and nucleic acid testing among blood donors in Majmaah, Saudi Arabia (2018)The prevalence of transfusion…Assessment of HIV transfusion transmission risk in South Africa: a 10‐year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes (2018)Assessment of HIV transfusion…Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa (2017)Use of Blood Donor Screening …Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia (2017)Three-Year Experience in NAT …Residual risk and waste in donated blood with pooled nucleic acid testing (2016)Residual risk and waste in do…Problems and Approaches for Blood Transfusion in the Developing Countries (2016)Problems and Approaches for B…Transmission of human immunodeficiency virus T ype‐1 by fresh‐frozen plasma treated with methylene blue and light (2015)Transmission of human immunod…Motivators and deterrents to blood donation among Black South Africans: a qualitative analysis of focus group data (2015)Motivators and deterrents to …The Use of Rapid Diagnostic Tests for Transfusion Infectious Screening in Africa: A Literature Review (2014)The Use of Rapid Diagnostic T…Prevalence of human immunodeficiency virus RNA and antibody in first‐time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios (2013)Prevalence of human immunodef…Comparative analysis of triplex nucleic acid test assays in United States blood donors (2013)Comparative analysis of tripl…Reduction of the risk of transfusion‐transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5‐year review (2012)Reduction of the risk of tran…The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood (2011)The challenges of meeting the…Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms (2010)Refinement of a viral transmi…Nucleic acid testing (NAT) in high prevalence–low resource settings (2010)Nucleic acid testing (NAT) in…Estimate of the residual risk of transfusion‐transmitted human immunodeficiency virus infection in sub‐Saharan Africa: a multinational collaborative study (2010)Estimate of the residual risk…The Risk of Transfusion-Transmitted Viral Infections (1996)Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. (2009)The risk of transfusion‐transmitted infections in sub‐Saharan Africa (2009)Moving on from voluntary non‐remunerated donors: who is the best blood donor? (2011)Blood transfusion in sub‐Saharan Africa: understanding the missing gap and responding to present and future challenges (2018)Seroprevalence of transfusion-transmissible infections among blood donors at National Blood Transfusion Service, Eritrea: a seven-year retrospective study (2018)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Infectivity of blood components from donors with occult hepatitis B infection – results from an Australian lookback programme (2014)Robust Postdonation Blood Screening Under Prevalence Rate Uncertainty (2017)Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations (2017)Current incidence and estimated residual risk of transfusion‐transmitted infections in donations made to Canadian Blood Services (2007)Transfusion safety in francophone African countries: an analysis of strategies for the medical selection of blood donors (2011)The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre. (2014)Prevalence, incidence and residual risk of transfusion-transmitted hepatitis C virus and human immunodeficiency virus after the implementation of nucleic acid testing in Italy: a 7-year (2009-2015) survey. (2018)The Measurement of Observer Agreement for Categorical Data (1977)Qualitative Research Methods for the Social Sciences (2000)Three Approaches to Qualitative Content Analysis (2005)Blood donation barriers and facilitators of Sub‐Saharan African migrants and minorities in Western high‐income countries: a systematic review of the literature (2018)Reasons of under-representation of Iranian women in blood donation (2020)Safe blood supply in sub-Saharan Africa: challenges and opportunities (2021)Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations (2011)The infectious risks in blood transfusion as of today – A no black and white situation (2016)Guidance for the procurement of COVID‐19 convalescent plasma: differences between high‐ and low‐middle‐income countries (2020)Assessing the global burden of hemorrhage: The global blood supply, deficits, and potential solutions (2021)Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 2016 (2020)HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men (2021)Blood: an epic history of medicine and commerce (1999)Blood: An Epic History of Medicine and Commerce (1999)Maternal mortality in sub‐Saharan Africa: the contribution of ineffective blood transfusion services (2008)Knowledge Level, Motivators and Barriers of Blood Donation among Students at Qatar University (2021)Lessons learned from the COVID‐19 pandemic blood supply crisis (2022)Status of hospital-based blood transfusion services in low-income and middle-income countries: a cross-sectional international survey (2022)Transfusion-transmitted infections (2007)Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Prevention of transfusion-transmitted infections (2019)Effect of HIV pre‐exposure prophylaxis (PrEP) on detection of early infection and its impact on the appropriate post‐PrEP deferral period (2020)The evolving blood donor deferral policy for men who have sex with men: impact on the risk of HIV transmission by transfusion in France (2020)Robust possibilistic programming to design a closed-loop blood supply chain network considering service-level maximization and lateral resupply (2022)
this work references cited by second hop

References

  • 2004Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing535 cited
  • 2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited

Cited by

  • 2010Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms131 cited
  • 2011The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood122 cited
  • 2016Problems and Approaches for Blood Transfusion in the Developing Countries81 cited
  • 2014The Use of Rapid Diagnostic Tests for Transfusion Infectious Screening in Africa: A Literature Review70 cited
  • 2013Comparative analysis of triplex nucleic acid test assays in United States blood donors62 cited
  • 2018Assessment of HIV transfusion transmission risk in South Africa: a 10‐year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes55 cited
  • 2015Motivators and deterrents to blood donation among Black South Africans: a qualitative analysis of focus group data52 cited
  • 2010Estimate of the residual risk of transfusion‐transmitted human immunodeficiency virus infection in sub‐Saharan Africa: a multinational collaborative study50 cited
  • 2013Prevalence of human immunodeficiency virus RNA and antibody in first‐time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

50 cited
  • 2010Nucleic acid testing (NAT) in high prevalence–low resource settings47 cited
  • 2012Reduction of the risk of transfusion‐transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5‐year review39 cited
  • 2018The prevalence of transfusion-transmitted infections and nucleic acid testing among blood donors in Majmaah, Saudi Arabia37 cited
  • 2017Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia30 cited
  • 2017Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa28 cited
  • 2015Transmission of human immunodeficiency virus T ype‐1 by fresh‐frozen plasma treated with methylene blue and light24 cited
  • 2016Residual risk and waste in donated blood with pooled nucleic acid testing24 cited